MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    Comparison of correlations of structural magnetic resonance imaging measures with smartphone-based active tests and clinical tests in Huntington’s disease

    J. Rennig, D. Hawellek, J. Dorn, F. Lipsmeier, S. Holiga, C. Simillion, S. Schobel, M. Lindemann (Basel, Switzerland)

    Objective: The current study aims to explore the similarities and differences between neuronal correlates of established clinical or novel Roche Huntington’s disease (HD) Digital Monitoring…
  • MDS Virtual Congress 2021

    PROPRIOSPINAL MYOCLONUS ASSOCIATED TO SARS-COV-2 RESPIRATORY INFECTION

    JL. Chico-Garcia, M. Villadoniga, I. Regidor-Bailly Baillieri, A. Caballero, A. Beltran-Corbellini, P. Parra-Diaz, F. Rodriguez-Jorge, A. Alonso-Canovas, JC. Martinez-Castrillo, I. Corral-Corral (Madrid, Spain)

    Objective: To describe a case of propriospinal myoclonus (PM) in the setting of respiratory infection by SARS-CoV-2. Background: PM is an uncommon movement disorder characterized…
  • MDS Virtual Congress 2021

    Analysis of the correlation between the raphe nucleus echo and neurological diseases with depression/anxiety.

    YAN. Shao, YI. Liu (Dalian, China)

    Objective: The objective of this study is to assess raphe nucleus echo whether can be used as a means to distinguish endogenous and reactive depression/anxiety, so as to…
  • MDS Virtual Congress 2021

    Utility of neurophysiological evaluation in movement disorders clinical practice

    T. Grippe, R. Chen (Toronto, Canada)

    Objective: To retrospectively evaluate the indications and final diagnoses of movement disorder neurophysiological evaluations in a specialized movement disorders centre. Background: The use of neurophysiological…
  • MDS Virtual Congress 2021

    “I’ve got cataracts and can’t read the information sheet about the medication you have given me”*

    P. Hobson, V. Adhiyaman (Rhyl, United Kingdom)

    Objective: This study reports People with Parkinson’s (PWP) perception on their illness, its meaning to them and their view of the interactions they have with…
  • MDS Virtual Congress 2021

    Risk of cancer in Parkinsons’s disease: a systematic review of diagnostic validity

    A. Mehdiyeva, V. Kaasinen, J. Mauri, J. Sipilä (Joensuu, Finland)

    Objective: We systematically reviewed studies to investigate a possible association between validated PD diagnoses and cancer risk. Background: An inverse association between Parkinson’s disease (PD)…
  • MDS Virtual Congress 2021

    Motor evaluation of Parkinson’s disease patients through video consultations in the Brazilian public health system – a real life feasibility study

    D. Dos Santos, D. Camelo, M. Strelow, M. Silva, P. Führ, L. Marins, A. Schumacher-Schuh (Porto Alegre, Brazil)

    Objective: To assess the feasibility and quality of evaluating motor symptoms through video consultations for Parkinson disease’s (PD) patients in the Brazilian public health system.…
  • MDS Virtual Congress 2021

    WATCH-PD: Wearable Assessments in the Clinic and Home in Parkinson’s Disease: Baseline Analyses

    J. Adams, E. Dorsey, T. Ruiz Herrero, P. Auinger, R. Alexander, R. Rubens, B. Tracey, N. Zach, P. O'Donnell, A. Best, J. Severson, M. Kostrzebski, E. Stevenson, P. Wilmot, Y. Pohlson, J. Cosman, K. Fisher, J. Edgerton, T. Kangarloo (Rochester, USA)

    Objective: To provide a profile of early Parkinson’s disease (PD) using clinical and digital measures and determine whether digital measures can differentiate PD and controls…
  • MDS Virtual Congress 2021

    Efficacy of opicapone according to different levodopa daily intakes in Parkinson’s disease patients with motor fluctuations

    G. Ebersbach, W. Poewe, J. Ferreira, D. Magalhaes, J. Rocha, P. Soares-da-Silva (Beelitz-Heilstätten, Germany)

    Objective: To evaluate the efficacy of opicapone (OPC) in Parkinson’s disease (PD) patients with motor fluctuation according to different levodopa daily intakes. Background: OPC proved…
  • MDS Virtual Congress 2021

    Effects of Opicapone on Sleep in Patients with Parkinson’s Disease and Motor Fluctuations

    R. Hauser, A. Videnovic, P. Soares-da-Silva, G. Liang, K. Olson, E. Jen, JF. Rocha, O. Klepitskaya (Miami, USA)

    Objective: To assess the effects of opicapone (OPC: 50 mg, once-daily) on sleep in patients with Parkinson’s disease (PD) and motor fluctuations. Background: OPC is…
  • « Previous Page
  • 1
  • …
  • 124
  • 125
  • 126
  • 127
  • 128
  • …
  • 132
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley